Penrose TherapeuTx
Manufacturing · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
46701 Commerce Center Dr, Plymouth, Mich...Phone Number
(734) 215-7050Website
www.penrosetherapeutx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Penrose TherapeuTx
Penrose TherapeuTx is a U.S.-based pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers. Penrose has pioneered the development of a novel Mitochondrial Modifying Agent therapeutic platform designed to generate therapies for difficult to treat cancers through a unique cooperative mechanism of action. Our approach has potential broad applicability across both hematologic and solid tumors.Explore more
Penrose TherapeuTx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Penrose TherapeuTx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Penrose TherapeuTx recently announced quarterly report
Check if Penrose TherapeuTx has recently received funding, and reach out quickly before it becomes old news!
Check out if Penrose TherapeuTx is spiking on competitors!
Product Launch: Get notified when Penrose TherapeuTx launches new products
Website visits: Recent activity has been detected on your website
Penrose TherapeuTx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Penrose TherapeuTx has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Penrose TherapeuTx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Penrose TherapeuTx
Recommended Actions
Find VP level buyers at Penrose TherapeuTx
Find 3 more new buyers
Company Profile Activity
Activity Insights
Penrose TherapeuTx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Penrose TherapeuTx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Penrose TherapeuTx.
Penrose TherapeuTx financials insights
Gather financial insights about Penrose TherapeuTx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Penrose TherapeuTx Tech Stack
A closer look at the technologies used by Penrose TherapeuTx
Most Recent Scoops
New Hire
Executive Move
New Hire
Executive Move
Funding
Penrose TherapeuTx has received an SBA PPP loan for $150,000-350,000 from JPMorgan Chase Bank.
Funding
Penrose TherapeuTx News & Media
Penrose TherapeuTx Appoints Pharmaceutical Leader David Sherris, Ph.D., as President and Chief Executive Officer
ANN ARBOR, Mich. & BOSTON--(BUSINESS WIRE)--Penrose TherapeuTx, a privately held clinical stage small molecule drug development company committed to improving patient lives through innovative oncology therapies, today announced the appointment of David Sherris, Ph.D. as President and Chief Executive Officer. Dr. Sherris has over 30 years of experience in translational medicine involving basic research, pharmaceuticals, and diagnostics, and has held numerous senior roles at prominent pharmaceutiFormer FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board
ANN ARBOR, Mich. & CHICAGO--(BUSINESS WIRE)--Penrose TherapeuTx, a pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers, today welcomed Dr. Vicki Seyfert-Margolis, Chief Executive Officer and Founder of MyOwnMed, to its scientific advisory board. A prominent strategic advisor in regulatory science, Dr. Seyfert-Margolis has nearly two decades of experience at the U.S. Food and Drug Administration (FDA) and the National Institute oPenrose TherapeuTx Expands Scientific Advisory Board with Three World-Renowned Oncology Researchers
ANN ARBOR, Mich. & CHICAGO--(BUSINESS WIRE)--Penrose TherapeuTx, a pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers, has welcomed three new leading oncology researchers to serve on the company’s advisory board. Penrose’s deep bench of scientific advisors will now also include Mircea Ivan, M.D., Ph.D., a microbiologist and immunologist whose research contributed to the 2019 Nobel Prize in Medicine or Physiology for the discoveProminent Mitochondrial Researcher Dr. Navdeep Chandel Joins Penrose TherapeuTx Scientific Advisory Board
ANN ARBOR, Mich. & CHICAGO--(BUSINESS WIRE)--Penrose TherapeuTx, a pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers, today announced that Navdeep Chandel, Ph.D. has joined the company’s scientific advisory board. Dr. Chandel has more than 20 years of experience in mitochondrial research and has contributed to significant breakthroughs in mitochondrial science, including understanding its role in cancer cells. He joins Penrose
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Penrose TherapeuTx
Sign Up For FreeTo access detailed company insights
Penrose TherapeuTx is a U.S.-based pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers. Penrose has pioneered the development of a novel Mitochondrial Modifying Agent therapeutic platform designed to generate therapies for difficult to treat cancers through a unique cooperative mech... Read More
